[Clinical and preclinical aspects of adrenal Cushing syndrome].
Cushing's syndrome of adrenal origin encompasses different entities: besides the occurrence of adenoma and carcinoma, a not homogeneous group includes the ACTH-independent macro- or micronodular bilateral hyperplasia and the familial pigmented nodular hyperplasia (Carney's syndrome). Moreover, isolated cases of immunological origin and food-dependence have recently described. On clinical grounds no major characteristics may help to identify the adrenal origin of Cushing's syndrome, except for few situations as carcinoma or nodular dysplasia. Laboratory investigations of patients with adrenocortical tumor are based on ACTH and cortisol determinations in basal conditions and in response to high dose dexamethasone and CRH tests. However, isolated diagnostic problems may occur, as the presence of a black adrenocortical adenoma or the uncommon persistence of a circadian rhythmicity of glucocorticoid secretion. The evaluation of new markers of bone turnover (BGP, ICTP) and of collagen turnover (PIIINP) confirms the existence of corticosteroid-induced bone and collagen damages and may also be a useful prognostic index after treatment. Although up to now food-dependent Cushing's syndrome appears to be very rare, the adrenocortical sensitivity to GIP has been investigated in patients with either pituitary Cushing's disease, or clinically silent adrenal masses. No evidence of GIP-dependent cortisol secretion during the peptide infusion or after endogenous stimulation by OGTT was observed in any case. Since the wide availability of sensitive and noninvasive imaging techniques (CT and NMR), in recent years the finding of incidentalomas has become fairly common. In patients with incidentaloma abnormalities of the endocrine function are frequently encountered, and the "preclinical" Cushing's syndrome is increasingly recognized.(ABSTRACT TRUNCATED AT 250 WORDS)
Ambrosi
B
B
Istituto di Scienze Endocrine, Ospedale Maggiore IRCCS, Università degli Studi-Milano.
Re
T
T
Passini
E
E
Peverelli
S
S
Sartorio
A
A
Colombo
P
P
D000236:Adenoma / Q000145:classification / Q000150:complications / Q000601:surgery; D000302:Adrenal Cortex / Q000473:pathology; D000306:Adrenal Cortex Neoplasms / Q000145:classification / Q000150:complications / Q000601:surgery; D000315:Adrenalectomy; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D015415:Biomarkers; D002277:Carcinoma / Q000150:complications / Q000601:surgery; D003480:Cushing Syndrome / Q000175:diagnosis / Q000209:etiology / Q000473:pathology / Q000601:surgery; D003907:Dexamethasone; D003952:Diagnostic Imaging; D005260:Female; D005749:Gastric Inhibitory Polypeptide; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism; D006965:Hyperplasia; D008297:Male; D010911:Pituitary Neoplasms / Q000150:complications; D012680:Sensitivity and Specificity
D015415:Biomarkers; D005749:Gastric Inhibitory Polypeptide; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone
Aspetti clinici e preclinici della sindrome di Cushing surrenalica.